Sign in Subscribe

Jean-Claude Muller

UK approves Kisunla for the treatment of Alzheimer’s disease but NICE …does not pay for it.

UK approves Kisunla for the treatment of Alzheimer’s disease but NICE …does not pay for it.

SPECIAL REPORT 24.12 On October 23, the UK Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the licensing of Eli Lilly’s Donanemab or Kisunla for the treatment of early stage Alzheimer’s disease, but the health technology agency National Institute for Health and Care Excellence (NICE) said

Current Leading Biopharmaceutical Products by Sales

Current Leading Biopharmaceutical Products by Sales

This document has been prepared by Jean-Claude Muller and is provided for information purposes only. The information contained herein has been obtained from sources believed to be reliable but is not warranted to be accurate or complete. The views presented are those of the author at the time of writing

L’Election à la Présidence Américaine et la « Trumpisation » de la Politique

L’Election à la Présidence Américaine et la « Trumpisation » de la Politique

SPECIAL REPORT 24.12 Mardi 15 octobre 2024, trois semaines avant les élections américaines. L’analyse des sondages des intentions de vote pour l’élection de la Présidence américaine entre Kamala Harris et Donald Trump montre une très grande homogénéité entre les différents médias ou instituts de sondage. Le New

Medicinal Chemistry: A great past, an underestimated future

Medicinal Chemistry: A great past, an underestimated future

SPECIAL REPORT 24.09 The following testimonial was delivered by Jean-Claude Muller, former President (1996-1998) of the European Federation for Medicinal chemistry and Chemical biology (EFMC) at the Opening Ceremony of the XXVIII EFMC-International Symposium on Medicinal Chemistry (ISMC) in Rome (Italy) on September 1, 2024. Dear Fellow Chemists Ever

Le système des retraites en France

Le système des retraites en France

Le système des retraites en France, repose sur un système simple et néanmoins original : celui de la répartition.

Human Induced Pluripotent Stem Cells as Innovative Therapies

Human Induced Pluripotent Stem Cells as Innovative Therapies

SPECIAL REPORT #21.26 Human Induced Pluripotent Stem Cells as Innovative Therapies When, in 2007, Professor Shinya Yamanaka disclosed its discovery that mature human cells could be transformed into stem cells, better known now as human induced Pluripotent Stem Cells (hiPSC), the biopharmaceutical community immediately recognised that this new biological

Parallèles entre exploration spatiale et exploration du cerveau

Parallèles entre exploration spatiale et exploration du cerveau

Posté le 6 novembre 2019 dans un Communiqués de presse par Charles Sagnes. L’exploration spatiale et l’exploration du cerveau, deux domaines qui semblent très éloignés sur le papier, ont, en fait, beaucoup de points communs et peuvent chacun apprendre l’un de l’autre pour le futur. Alcimed,